APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prenatal Second-Generation DNA Sequencing

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Prenatal Second-Generation DNA Sequencing Industry Growth and Trends Forecast to 2032

11 April 2026114 pages

Choose your research edition.

Industry ResearchPrenatal Second-Generation DNA Sequencing Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Prenatal Second-Generation DNA Sequencing Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Prenatal Second-Generation DNA Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prenatal Second-Generation DNA Sequencing Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Prenatal Second-Generation DNA Sequencing Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

According to APO Research, the global Prenatal Second-Generation DNA Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Prenatal Second-Generation DNA Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Prenatal Second-Generation DNA Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prenatal Second-Generation DNA Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Prenatal Second-Generation DNA Sequencing market include Natera, Labcorp, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB and Myriad Genetics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Prenatal Second-Generation DNA Sequencing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Prenatal Second-Generation DNA Sequencing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prenatal Second-Generation DNA Sequencing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prenatal Second-Generation DNA Sequencing.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Prenatal Second-Generation DNA Sequencing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Prenatal Second-Generation DNA Sequencing Market by Company

Natera

Labcorp

Quest Diagnostics

MedGenome

Mayo Clinic Laboratories

GeneDx

PreventionGenetics

SYNLAB

Myriad Genetics

GGA

Fulgent Genetics

Rainbow Genomics

BillionToOne

BGI Genomics

Berry Genomics

Annaroad

Weihansi Biomedical Technology

Prenatal Second-Generation DNA Sequencing Segment by Type

Targeted Panels

Exome Sequencing

Others

Prenatal Second-Generation DNA Sequencing Segment by Application

Public Hospitals

Private Hospitals

Prenatal Second-Generation DNA Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prenatal Second-Generation DNA Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prenatal Second-Generation DNA Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prenatal Second-Generation DNA Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Prenatal Second-Generation DNA Sequencing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Prenatal Second-Generation DNA Sequencing Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Prenatal Second-Generation DNA Sequencing Market Share by Region (2021-2026) Table 4. Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Prenatal Second-Generation DNA Sequencing Market Share by Region (2027-2032) Table 6. Global Prenatal Second-Generation DNA Sequencing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Prenatal Second-Generation DNA Sequencing Market Size Share by Type (2021-2026) Table 9. Global Prenatal Second-Generation DNA Sequencing Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Prenatal Second-Generation DNA Sequencing Market Size Share Forecasted by Type (2027-2032) Table 11. North America Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Prenatal Second-Generation DNA Sequencing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Prenatal Second-Generation DNA Sequencing Market Size Share by Application (2021-2026) Table 24. Global Prenatal Second-Generation DNA Sequencing Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Prenatal Second-Generation DNA Sequencing Market Size Share Forecasted by Application (2027-2032) Table 26. North America Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Prenatal Second-Generation DNA Sequencing Industry Trends Table 37. Prenatal Second-Generation DNA Sequencing Industry Drivers Table 38. Prenatal Second-Generation DNA Sequencing Industry Opportunities and Challenges Table 39. Prenatal Second-Generation DNA Sequencing Industry Restraints Table 40. Global Prenatal Second-Generation DNA Sequencing Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Company (2021-2026) Table 42. Global Prenatal Second-Generation DNA Sequencing Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Prenatal Second-Generation DNA Sequencing Key Company Headquarters & Area Served Table 44. Global Prenatal Second-Generation DNA Sequencing Company, Product Type & Application Table 45. Global Prenatal Second-Generation DNA Sequencing Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Prenatal Second-Generation DNA Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Natera Company Information Table 49. Natera Business Overview Table 50. Natera Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Natera Prenatal Second-Generation DNA Sequencing Product Portfolio Table 52. Natera Recent Development Table 53. Labcorp Company Information Table 54. Labcorp Business Overview Table 55. Labcorp Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Labcorp Prenatal Second-Generation DNA Sequencing Product Portfolio Table 57. Labcorp Recent Development Table 58. Quest Diagnostics Company Information Table 59. Quest Diagnostics Business Overview Table 60. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 62. Quest Diagnostics Recent Development Table 63. MedGenome Company Information Table 64. MedGenome Business Overview Table 65. MedGenome Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. MedGenome Prenatal Second-Generation DNA Sequencing Product Portfolio Table 67. MedGenome Recent Development Table 68. Mayo Clinic Laboratories Company Information Table 69. Mayo Clinic Laboratories Business Overview Table 70. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Product Portfolio Table 72. Mayo Clinic Laboratories Recent Development Table 73. GeneDx Company Information Table 74. GeneDx Business Overview Table 75. GeneDx Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. GeneDx Prenatal Second-Generation DNA Sequencing Product Portfolio Table 77. GeneDx Recent Development Table 78. PreventionGenetics Company Information Table 79. PreventionGenetics Business Overview Table 80. PreventionGenetics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. PreventionGenetics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 82. PreventionGenetics Recent Development Table 83. SYNLAB Company Information Table 84. SYNLAB Business Overview Table 85. SYNLAB Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. SYNLAB Prenatal Second-Generation DNA Sequencing Product Portfolio Table 87. SYNLAB Recent Development Table 88. Myriad Genetics Company Information Table 89. Myriad Genetics Business Overview Table 90. Myriad Genetics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Myriad Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 92. Myriad Genetics Recent Development Table 93. GGA Company Information Table 94. GGA Business Overview Table 95. GGA Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. GGA Prenatal Second-Generation DNA Sequencing Product Portfolio Table 97. GGA Recent Development Table 98. Fulgent Genetics Company Information Table 99. Fulgent Genetics Business Overview Table 100. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 102. Fulgent Genetics Recent Development Table 103. Rainbow Genomics Company Information Table 104. Rainbow Genomics Business Overview Table 105. Rainbow Genomics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Rainbow Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 107. Rainbow Genomics Recent Development Table 108. BillionToOne Company Information Table 109. BillionToOne Business Overview Table 110. BillionToOne Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. BillionToOne Prenatal Second-Generation DNA Sequencing Product Portfolio Table 112. BillionToOne Recent Development Table 113. BGI Genomics Company Information Table 114. BGI Genomics Business Overview Table 115. BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. BGI Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 117. BGI Genomics Recent Development Table 118. Berry Genomics Company Information Table 119. Berry Genomics Business Overview Table 120. Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Berry Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio Table 122. Berry Genomics Recent Development Table 123. Annaroad Company Information Table 124. Annaroad Business Overview Table 125. Annaroad Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Annaroad Prenatal Second-Generation DNA Sequencing Product Portfolio Table 127. Annaroad Recent Development Table 128. Weihansi Biomedical Technology Company Information Table 129. Weihansi Biomedical Technology Business Overview Table 130. Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Product Portfolio Table 132. Weihansi Biomedical Technology Recent Development Table 133. North America Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2026) Table 136. North America Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Prenatal Second-Generation DNA Sequencing Market Share Forecast by Country (2027-2032) Table 138. Europe Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2026) Table 141. Europe Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Prenatal Second-Generation DNA Sequencing Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2026) Table 146. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Share Forecast by Country (2027-2032) Table 148. Latin America Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2026) Table 151. Latin America Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Prenatal Second-Generation DNA Sequencing Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2026) Table 156. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Prenatal Second-Generation DNA Sequencing Product Image Figure 3. Global Prenatal Second-Generation DNA Sequencing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Prenatal Second-Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 5. Global Prenatal Second-Generation DNA Sequencing Market Share by Region: 2025 VS 2032 Figure 6. Global Prenatal Second-Generation DNA Sequencing Market Share by Region (2021-2032) Figure 7. North America Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Targeted Panels Image Figure 13. Global Targeted Panels Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Exome Sequencing Image Figure 15. Global Exome Sequencing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Prenatal Second-Generation DNA Sequencing Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Prenatal Second-Generation DNA Sequencing Market Share by Type 2025 VS 2032 Figure 20. North America Prenatal Second-Generation DNA Sequencing Market Size Share by Type (2021-2032) Figure 21. Europe Prenatal Second-Generation DNA Sequencing Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Share by Type (2021-2032) Figure 23. Latin America Prenatal Second-Generation DNA Sequencing Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size Share by Type (2021-2032) Figure 25. Public Hospitals Image Figure 26. Global Public Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Private Hospitals Image Figure 28. Global Private Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Prenatal Second-Generation DNA Sequencing Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Prenatal Second-Generation DNA Sequencing Market Share by Application 2025 VS 2032 Figure 31. North America Prenatal Second-Generation DNA Sequencing Market Size Share by Application (2021-2032) Figure 32. Europe Prenatal Second-Generation DNA Sequencing Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Share by Application (2021-2032) Figure 34. Latin America Prenatal Second-Generation DNA Sequencing Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Prenatal Second-Generation DNA Sequencing Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Prenatal Second-Generation DNA Sequencing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Prenatal Second-Generation DNA Sequencing Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2032) Figure 41. Europe Prenatal Second-Generation DNA Sequencing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Prenatal Second-Generation DNA Sequencing Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2032) Figure 44. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2032) Figure 47. Latin America Prenatal Second-Generation DNA Sequencing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Prenatal Second-Generation DNA Sequencing Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2032) Figure 50. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Panels
  • Exome Sequencing
  • Others
Applications
  • Public Hospitals
  • Private Hospitals
Companies covered
  • Natera
  • Labcorp
  • Quest Diagnostics
  • MedGenome
  • Mayo Clinic Laboratories
  • GeneDx
  • PreventionGenetics
  • SYNLAB
  • Myriad Genetics
  • GGA
  • Fulgent Genetics
  • Rainbow Genomics
  • BillionToOne
  • BGI Genomics
  • Berry Genomics
  • Annaroad
  • Weihansi Biomedical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Prenatal Second-Generation DNA Sequencing Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2021-2032)
  5. 1.4.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2021-2026)
  6. 1.4.2 Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2027-2032)
  7. 1.5 Key Regions Prenatal Second-Generation DNA Sequencing Market Size (2021-2032)
  8. 1.5.1 North America Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (2021-2032)
2 Prenatal Second-Generation DNA Sequencing Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Targeted Panels
  3. 2.1.2 Exome Sequencing
  4. 2.1.3 Others
  5. 2.2 Global Prenatal Second-Generation DNA Sequencing Market Size by Type
  6. 2.2.1 Global Prenatal Second-Generation DNA Sequencing Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Prenatal Second-Generation DNA Sequencing Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Prenatal Second-Generation DNA Sequencing Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Prenatal Second-Generation DNA Sequencing Market Size by Regions
  10. 2.3.1 North America Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Type (2021-2026)
3 Prenatal Second-Generation DNA Sequencing Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Public Hospitals
  3. 3.1.2 Private Hospitals
  4. 3.2 Global Prenatal Second-Generation DNA Sequencing Market Size by Application
  5. 3.2.1 Global Prenatal Second-Generation DNA Sequencing Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Prenatal Second-Generation DNA Sequencing Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Prenatal Second-Generation DNA Sequencing Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Prenatal Second-Generation DNA Sequencing Market Size by Regions
  9. 3.3.1 North America Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Prenatal Second-Generation DNA Sequencing Industry Trends
  2. 4.2 Prenatal Second-Generation DNA Sequencing Industry Drivers
  3. 4.3 Prenatal Second-Generation DNA Sequencing Industry Opportunities and Challenges
  4. 4.4 Prenatal Second-Generation DNA Sequencing Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Prenatal Second-Generation DNA Sequencing Revenue (2021-2026)
  2. 5.2 Global Prenatal Second-Generation DNA Sequencing Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Prenatal Second-Generation DNA Sequencing Key Company Headquarters & Area Served
  4. 5.4 Global Prenatal Second-Generation DNA Sequencing Company, Product Type & Application
  5. 5.5 Global Prenatal Second-Generation DNA Sequencing Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Prenatal Second-Generation DNA Sequencing Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Prenatal Second-Generation DNA Sequencing Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Prenatal Second-Generation DNA Sequencing Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Natera
  2. 6.1.1 Natera Company Information
  3. 6.1.2 Natera Business Overview
  4. 6.1.3 Natera Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Natera Prenatal Second-Generation DNA Sequencing Product Portfolio
  6. 6.1.5 Natera Recent Developments
  7. 6.2 Labcorp
  8. 6.2.1 Labcorp Company Information
  9. 6.2.2 Labcorp Business Overview
  10. 6.2.3 Labcorp Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Labcorp Prenatal Second-Generation DNA Sequencing Product Portfolio
  12. 6.2.5 Labcorp Recent Developments
  13. 6.3 Quest Diagnostics
  14. 6.3.1 Quest Diagnostics Company Information
  15. 6.3.2 Quest Diagnostics Business Overview
  16. 6.3.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Portfolio
  18. 6.3.5 Quest Diagnostics Recent Developments
  19. 6.4 MedGenome
  20. 6.4.1 MedGenome Company Information
  21. 6.4.2 MedGenome Business Overview
  22. 6.4.3 MedGenome Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 MedGenome Prenatal Second-Generation DNA Sequencing Product Portfolio
  24. 6.4.5 MedGenome Recent Developments
  25. 6.5 Mayo Clinic Laboratories
  26. 6.5.1 Mayo Clinic Laboratories Company Information
  27. 6.5.2 Mayo Clinic Laboratories Business Overview
  28. 6.5.3 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Product Portfolio
  30. 6.5.5 Mayo Clinic Laboratories Recent Developments
  31. 6.6 GeneDx
  32. 6.6.1 GeneDx Company Information
  33. 6.6.2 GeneDx Business Overview
  34. 6.6.3 GeneDx Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 GeneDx Prenatal Second-Generation DNA Sequencing Product Portfolio
  36. 6.6.5 GeneDx Recent Developments
  37. 6.7 PreventionGenetics
  38. 6.7.1 PreventionGenetics Company Information
  39. 6.7.2 PreventionGenetics Business Overview
  40. 6.7.3 PreventionGenetics Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 PreventionGenetics Prenatal Second-Generation DNA Sequencing Product Portfolio
  42. 6.7.5 PreventionGenetics Recent Developments
  43. 6.8 SYNLAB
  44. 6.8.1 SYNLAB Company Information
  45. 6.8.2 SYNLAB Business Overview
  46. 6.8.3 SYNLAB Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 SYNLAB Prenatal Second-Generation DNA Sequencing Product Portfolio
  48. 6.8.5 SYNLAB Recent Developments
  49. 6.9 Myriad Genetics
  50. 6.9.1 Myriad Genetics Company Information
  51. 6.9.2 Myriad Genetics Business Overview
  52. 6.9.3 Myriad Genetics Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Myriad Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio
  54. 6.9.5 Myriad Genetics Recent Developments
  55. 6.10 GGA
  56. 6.10.1 GGA Company Information
  57. 6.10.2 GGA Business Overview
  58. 6.10.3 GGA Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 GGA Prenatal Second-Generation DNA Sequencing Product Portfolio
  60. 6.10.5 GGA Recent Developments
  61. 6.11 Fulgent Genetics
  62. 6.11.1 Fulgent Genetics Company Information
  63. 6.11.2 Fulgent Genetics Business Overview
  64. 6.11.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Portfolio
  66. 6.11.5 Fulgent Genetics Recent Developments
  67. 6.12 Rainbow Genomics
  68. 6.12.1 Rainbow Genomics Company Information
  69. 6.12.2 Rainbow Genomics Business Overview
  70. 6.12.3 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio
  72. 6.12.5 Rainbow Genomics Recent Developments
  73. 6.13 BillionToOne
  74. 6.13.1 BillionToOne Company Information
  75. 6.13.2 BillionToOne Business Overview
  76. 6.13.3 BillionToOne Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 BillionToOne Prenatal Second-Generation DNA Sequencing Product Portfolio
  78. 6.13.5 BillionToOne Recent Developments
  79. 6.14 BGI Genomics
  80. 6.14.1 BGI Genomics Company Information
  81. 6.14.2 BGI Genomics Business Overview
  82. 6.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 BGI Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio
  84. 6.14.5 BGI Genomics Recent Developments
  85. 6.15 Berry Genomics
  86. 6.15.1 Berry Genomics Company Information
  87. 6.15.2 Berry Genomics Business Overview
  88. 6.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Berry Genomics Prenatal Second-Generation DNA Sequencing Product Portfolio
  90. 6.15.5 Berry Genomics Recent Developments
  91. 6.16 Annaroad
  92. 6.16.1 Annaroad Company Information
  93. 6.16.2 Annaroad Business Overview
  94. 6.16.3 Annaroad Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Annaroad Prenatal Second-Generation DNA Sequencing Product Portfolio
  96. 6.16.5 Annaroad Recent Developments
  97. 6.17 Weihansi Biomedical Technology
  98. 6.17.1 Weihansi Biomedical Technology Company Information
  99. 6.17.2 Weihansi Biomedical Technology Business Overview
  100. 6.17.3 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Product Portfolio
  102. 6.17.5 Weihansi Biomedical Technology Recent Developments
7 North America
  1. 7.1 North America Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026)
  3. 7.3 North America Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026)
  3. 8.3 Europe Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026)
  3. 10.3 South America Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst